Choosing the Right Target for Saliva THC Screening

Created on 10.20

Why parent THC—not its metabolites—is the practical choice for rapid on-site testing

Saliva cannabis testing is often described as a simple positive or negative. In reality, what the result means depends on one key choice: whether the test looks for the original drug, THC, or for the compounds the body breaks it down into. That choice affects what the test can detect, how long after use it remains useful, and whether the method can realistically be used at the point of care.

What's Actually in Oral Fluid After Cannabis Use

When cannabis is inhaled or ingested, Δ⁹-THC enters the bloodstream and is processed mainly by the liver. It first becomes 11-OH-THC, an active metabolite, and then THC-COOH, an inactive metabolite. Urine and blood tests often target THC-COOH because it is relatively easy to detect in those body fluids.

Oral fluid is different. In saliva, the dominant cannabinoid is usually parent THC—the original drug molecule. THC is highly lipophilic, meaning it does not pass easily from blood into saliva. Much of the THC found in oral fluid after smoking or vaping is therefore drug residue left in the mouth, rather than drug transferred from the bloodstream. Controlled studies have repeatedly confirmed this. Specifically, THC does not appear to be transferred from plasma to saliva and is sequestered in the buccal cavity during smoking, and the oral cavity "depot" represents the primary or sole source of THC found in oral fluid after controlled smoked cannabis administration.

This is why oral-fluid testing commonly screens for parent THC, while urine and blood testing often target THC-COOH. 

The Detection Challenge: Parent THC vs. THC-COOH

In oral fluid, THC-COOH is the more analytically difficult target. A 2024 LC-MS/MS method illustrates the difference clearly: the working calibration range was 0.1–50 ng/mL for THC, but only 0.05–1 ng/mL for THC-COOH. The upper limit differs by a factor of 50, reflecting the much lower abundance of the metabolite in this matrix.

In a controlled study of chronic daily cannabis smokers, GC-MS limits of quantification were 0.5 μg/L for THC but 7.5 ng/L for THC-COOH—nearly a two-order-of-magnitude difference in the sensitivity required.In plain terms, detecting THC-COOH reliably requires high-sensitivity laboratory instruments such as LC-MS/MS or GC-MS/MS, not a simple point-of-care immunoassay strip. Parent THC, by contrast, is present at levels that rapid chromatographic immunoassays can detect at practical cut-offs.

How Long THC Remains Detectable in Saliva

Parent THC has a relatively short detection window in saliva. Because oral-fluid THC is strongly influenced by recent oral contamination, it is generally detectable for up to about 24 hours after use, with the highest concentrations shortly after smoking or vaping. Some chronic users may show detectable THC for longer, but parent THC is not a long-term marker of past exposure.

For on-site screening programmes, the practical question is usually "has this person used cannabis recently?" 

Design Choices That Make a Difference

The One Step Marijuana (THC) Screen Test Device is a rapid chromatographic immunoassay designed for the qualitative detection of Δ⁹-THC in human saliva. It is available with cut-off options of 15 ng/mL, 30 ng/mL, or 50 ng/mL, allowing testing programmes to select a sensitivity appropriate to their objectives.

A more hygienic design: separate swab and test strip. Many rapid oral-fluid drug test devices use a one-piece design in which the saliva swab is physically connected to the test strip. This is convenient, but it creates a manufacturing challenge: once the swab and strip are joined, it is difficult to disinfect or sterilize the swab portion independently without affecting the strip or the device housing.

The One Step Marijuana (THC) Screen Test Device uses a separate swab-and-cassette design. The saliva swab is supplied in its own pouch, which can undergo independent disinfection or sterilization processing, while the test cassette is packaged separately. At the point of use, the swab is inserted into the cassette holder. Compared with integrated devices, this separation supports a more hygienic workflow and reduces the risk of cross-contamination.

Material selection: overcoming THC adsorption. THC is highly lipophilic, which creates a less obvious but important analytical problem: the parent drug can adsorb onto the surfaces of collection swabs, plastic housings, and fluid pathways. In oral-fluid testing, recovery can therefore vary with the collection material and device design.For a rapid THC immunoassay, uncontrolled adsorption can reduce the amount of analyte reaching the test strip and compromise reproducibility, especially at low ng/mL cut-offs.

The One Step Marijuana (THC) Screen Test Device was developed through systematic material selection and repeated reproducibility testing. Candidate materials for the swab, cassette, and fluid pathway were evaluated for their tendency to retain THC; the final configuration was selected for its ability to release THC consistently into the test system. This material optimization is intended to support stable detection of parent THC at the device's 15/30/50 ng/mL cut-offs, rather than allowing lipophilic adsorption to become a hidden source of variability.

The Bottom Line

For rapid on-site saliva screening, the analytical target matters. Parent THC is present at higher, more practical levels and is well suited to rapid chromatographic immunoassay. The One Step Marijuana (THC) Screen Test Device applies this principle—qualitative detection of Δ⁹-THC in human saliva at 15/30/50 ng/mL cut-offs—for practical, non-invasive screening of recent cannabis exposure. Its separate swab-and-cassette design further supports a hygienic collection workflow.

The device is intended for qualitative screening. Presumptive positive results should be confirmed by a laboratory method before definitive action.